Purdue, Sacklers Finalize $7.4B Opioid Settlement Deal
Purdue, Sacklers Finalize $7.4B Opioid Settlement Deal

Purdue, Sacklers Finalize $7.4B Opioid Settlement Deal

News summary

Purdue Pharma and the Sackler family have agreed to a $7.4 billion settlement with all 50 U.S. states, Washington D.C., and several territories, resolving litigation over their role in the opioid crisis. If approved by a federal judge, the deal will end Sackler ownership of Purdue and bar them from future opioid sales in the U.S. Settlement funds will be distributed over 15 years, with more than half paid out in the early years to support addiction treatment, prevention, and recovery. Individual victims, local governments, and others have until September 30 to vote on the agreement. Payment amounts to states will vary, with some states like West Virginia receiving accelerated disbursements due to the crisis's severity. The deal is among the largest in a series of opioid settlements that have collectively secured about $50 billion to combat the epidemic.

Story Coverage
Bias Distribution
67% Left
Information Sources
6a5fa75f-07b0-476b-9b52-290e520bbbb4bfb2a97b-336e-48d9-b69a-147df7862dc2d387b58c-602b-49e7-8f0e-990aad2baa47ee2e2e88-f60f-46ba-af3a-dd7892b6c73c
+11
Left 67%
Center 27%
R
Coverage Details
Total News Sources
24
Left
10
Center
4
Right
1
Unrated
9
Last Updated
23 days ago
Bias Distribution
67% Left
Related News
Daily Index

Negative

23Serious

Neutral

Optimistic

Positive

Ask VT AI
Story Coverage

Related Topics

Subscribe

Stay in the know

Get the latest news, exclusive insights, and curated content delivered straight to your inbox.

Present

Gift Subscriptions

The perfect gift for understanding
news from all angles.

Related News
Recommended News